Cécile Demur

4.7k citations
79 papers · 3.4k indexed · 1 hit paper · h-index 29

Impact in

  • Hematology top 0.5%
    • Acute Myeloid Leukemia Research
    • Chronic Myeloid Leukemia Treatments
    • Microtubule and mitosis dynamics

Papers in

    • Acute Myeloid Leukemia Research 36
    • Chronic Myeloid Leukemia Treatments 10
    • Myeloproliferative Neoplasms: Diagnosis and Treatment 7
    • Chronic Lymphocytic Leukemia Research 6

Cécile Demur

77 papers receiving 3.4k citations

Hit Papers

VX-680, a potent and selective small-molecule inhibitor of the Aurora kinases, suppresses tumor growth in vivo 2004 · 782 citations
7822004202620112018250500750

Peers

Cécile Demur
Comparison fields: 5 of 106
  • Hematology 1.2k
  • Cell Biology 698
  • Genetics 454
  • Oncology 1.0k
  • Molecular Biology 2.0k
Replace Emma Shtivelman with:
Emma Shtivelman United States
Yair Gazitt United States
Jin‐Chen Yu China
Alejandro Gutiérrez United States
Alexandre Puissant France
Stany Chrétien France
Fausto Grignani Italy
Andrew J. Paterson United States
Constantine Mitsiades United States
Miriam Erlacher Germany
Cécile Demur relative to Emma Shtivelman United States Emma Shtivelman's profile →
Citations per field
00.5×1.5×1.8×
Emma Shtivelman · 1×
Citations per year

Countries citing papers authored by Cécile Demur

Since Specialization
Citations

This map shows the geographic impact of Cécile Demur's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Cécile Demur with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Cécile Demur more than expected).

Fields of papers citing papers by Cécile Demur

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Cécile Demur. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Cécile Demur. The network helps show where Cécile Demur may publish in the future.

Co-authors

The 25 scholars most cited alongside Cécile Demur, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.

Border = papers with Cécile Demur Line = papers co-authored together Cécile Demur links everyone, so they are left out of the graph.

All Works

20 of 20 papers shown
#Work
1 201521
2 201327
3 201281
4 2011147
5 201116
6 201144
7 20100
8 200957
9 200944
10 200842
11 200827
12 200820
13 200722
14
La voie PI3K/Akt/mTOR : une nouvelle cible thérapeutique dans le traitement des leucémies aiguës myéloïdes
200611
15 200438
16
Lymphome anaplasique : (I) Forme leucémique de la variante « à petites cellules »chez un enfant
20001
17 19989
18 199862
19 199725
20 198813

About Cécile Demur

Cécile Demur is a scholar working on Hematology, Genetics, Molecular Biology, Immunology and Oncology, having authored 79 papers that have together received 3.4k indexed citations. Recurring topics across this work include Acute Myeloid Leukemia Research (36 papers), Chronic Myeloid Leukemia Treatments (10 papers), Acute Lymphoblastic Leukemia research (9 papers), Myeloproliferative Neoplasms: Diagnosis and Treatment (7 papers), Chronic Lymphocytic Leukemia Research (6 papers), Immune Cell Function and Interaction (6 papers), PI3K/AKT/mTOR signaling in cancer (6 papers) and Cancer therapeutics and mechanisms (5 papers). The work is most often cited by research in Hematology (1.2k citations), Cell Biology (698 citations), Genetics (454 citations), Oncology (1.0k citations) and Molecular Biology (2.0k citations). Cécile Demur has collaborated with scholars based in France, United States and New Zealand. Frequent co-authors include Christian Récher, Bernard Payrastre, Véronique Mansat‐De Mas, Guy Laurent, Cédric Dos Santos, David Bebbington, Elizabeth A. Harrington, Tomoko Nakayama, Michael Su and Thierry Hercend. Their work appears in journals such as Blood, Leukemia, Oncogene, British Journal of Haematology and Leukemia Research.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026